CRBN (cereblon) is the substrate-recognition subunit of a CRL4 cullin-RING E3 ubiquitin ligase, the DCX/CRL4(CRBN) complex composed of DDB1, CUL4A or CUL4B, RBX1 and CRBN. Through an N-terminal Lon-protease-like domain it binds the adaptor DDB1, and through a C-terminal thalidomide-binding (CULT) domain that coordinates a structural Zn2+ ion it recruits substrate proteins for ubiquitination and subsequent proteasomal degradation. Endogenous substrates include MEIS2, glutamine synthetase (GLUL) and ILF2, and the complex is required for normal limb outgrowth and FGF8 expression in vertebrates. CRBN also regulates neuronal large-conductance Ca2+-activated potassium (BK) channels via interaction with KCNT1, contributing to presynaptic glutamate release, memory and learning; loss-of-function variants cause autosomal recessive intellectual developmental disorder. The CULT domain is the direct molecular target of thalidomide, lenalidomide and pomalidomide (IMiDs) and of newer molecular-glue and PROTAC degraders, which act as molecular glues that reprogram CRBN substrate specificity to recruit neosubstrates such as IKZF1, IKZF3, SALL4, CK1alpha and GSPT1 for degradation. CRBN is expressed widely and most highly in brain, and localizes to cytoplasm, nucleus and peripheral membranes.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0005634
nucleus
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: CRBN is found in the nucleus as well as the cytoplasm by direct immunolocalization, consistent with this phylogenetic transfer.
Reason: Nuclear localization is supported by direct experimental evidence (PMID:20223979, IDA) and is consistent with the substrate-receptor role; the IBA transfer to nucleus is reasonable. It is a localization rather than the core molecular function.
Supporting Evidence:
PMID:20223979
CRBN is a thalidomide-binding protein that forms an E3 ubiquitin ligase complex with DDB1 and Cul4A; subcellular localization studies place it in the nucleus and cytoplasm.
|
|
GO:0030177
positive regulation of Wnt signaling pathway
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: CRBN promotes Wnt-induced, IMiD-independent degradation of CK1alpha (a negative regulator of Wnt), and is required for physiological Wnt signaling with conserved Wnt phenotypes in zebrafish and Drosophila.
Reason: This regulatory role is experimentally supported (PMID:34489457) and conserved, so the phylogenetic transfer is justified, but it is a downstream physiological consequence of the E3-ligase activity rather than CRBN's core substrate-receptor function.
Supporting Evidence:
PMID:34489457
CRBN is required for physiological Wnt signaling, as modulation of CRBN in zebrafish and Drosophila yields Wnt-driven phenotypes.
|
|
GO:0043161
proteasome-mediated ubiquitin-dependent protein catabolic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: As the substrate receptor of CRL4(CRBN), CRBN targets substrates for ubiquitination and proteasomal degradation; this is a core biological process for the gene.
Reason: Directly supported by experimental evidence (PMID:20223979 IMP; PMID:26131937 showing cullin/proteasome-dependent substrate degradation) and a central function.
Supporting Evidence:
PMID:26131937
The lenalidomide-dependent decrease in CK1alpha protein level was abrogated by treatment with the proteasome inhibitor MG132 and the NEDD8-activating enzyme inhibitor MLN4924, which interferes with the activity of cullin-RING E3 ubiquitin ligases, implicating proteasome- and cullin-dependent degradation of CK1alpha.
|
|
GO:0060173
limb development
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: The CRBN-containing CRL4 complex is required for normal limb outgrowth and FGF8 expression in zebrafish and chicks; thalidomide inhibition of this activity underlies its teratogenic limb defects.
Reason: This developmental phenotype is supported (PMID:20223979) and explains thalidomide teratogenicity, but it is a tissue/developmental consequence of the core E3-ligase function rather than the molecular function itself.
Supporting Evidence:
PMID:20223979
CRBN forms an E3 ubiquitin ligase complex with damaged DNA binding protein 1 (DDB1) and Cul4A that is important for limb outgrowth and expression of the fibroblast growth factor Fgf8 in zebrafish and chicks.
|
|
GO:0031464
Cul4A-RING E3 ubiquitin ligase complex
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: CRBN is the substrate-receptor component of the CUL4A-RBX1-DDB1-CRBN (CRL4) E3 ubiquitin ligase complex.
Reason: Core, well-established complex membership supported by direct experimental and structural evidence (PMID:20223979 IDA, PMID:25108355).
Supporting Evidence:
PMID:20223979
CRBN forms an E3 ubiquitin ligase complex with damaged DNA binding protein 1 (DDB1) and Cul4A.
|
|
GO:0005634
nucleus
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: Nuclear localization, transferred from UniProt subcellular location; corroborated by direct immunolocalization (PMID:20223979).
Reason: Redundant with the experimentally supported IDA nucleus annotation; localization, not core function.
Supporting Evidence:
PMID:20223979
Subcellular localization analysis showed CRBN in the nucleus and cytoplasm.
|
|
GO:0005737
cytoplasm
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: Cytoplasmic localization, transferred from UniProt subcellular location; corroborated by direct immunolocalization (PMID:20223979).
Reason: Redundant with the experimentally supported IDA cytoplasm annotation; localization, not core function.
Supporting Evidence:
PMID:20223979
Subcellular localization analysis showed CRBN in the nucleus and cytoplasm.
|
|
GO:0016020
membrane
|
IEA
GO_REF:0000044 |
KEEP AS NON CORE |
Summary: CRBN is annotated as a peripheral membrane protein (by similarity), consistent with its interaction with membrane ion channels such as KCNT1/BK channels.
Reason: The very general "membrane" term reflects a peripheral membrane association (by similarity, UniProt) related to its channel-regulatory role; retained as a non-core location but uninformative as to function.
Supporting Evidence:
file:human/CRBN/CRBN-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Membrane; Peripheral membrane protein.
|
|
GO:0005515
protein binding
|
IPI
PMID:25416956 A proteome-scale map of the human interactome network. |
MARK AS OVER ANNOTATED |
Summary: Bare protein binding from a high-throughput binary interactome map (HuRI), reporting interactions with RBPMS and PAK5.
Reason: GO:0005515 protein binding is uninformative and these high-throughput interactors (RBPMS, PAK5) have no established functional relationship to CRBN's E3-ligase role; per curation guidance bare protein binding should not be retained as informative.
Supporting Evidence:
PMID:25416956
A proteome-scale map of the human interactome network.
|
|
GO:0005515
protein binding
|
IPI
PMID:26131937 Lenalidomide induces ubiquitination and degradation of CK1ฮฑ ... |
MARK AS OVER ANNOTATED |
Summary: Protein-binding annotation derived from the lenalidomide study; the interactors are DDB1 (complex partner) and CK1alpha (a strictly IMiD-induced neosubstrate).
Reason: The underlying interactions are biologically meaningful (DDB1 defines complex membership; CK1alpha is a lenalidomide-induced neosubstrate), but the generic protein binding term is uninformative; the meaningful content is captured by the CRL4 complex-membership and ubiquitination/catabolism annotations and proposed substrate-adaptor MF.
Supporting Evidence:
PMID:26131937
Lenalidomide induces the ubiquitination of casein kinase 1A1 (CK1alpha) by the E3 ubiquitin ligase CUL4-RBX1-DDB1-CRBN (known as CRL4(CRBN)).
|
|
GO:0005515
protein binding
|
IPI
PMID:26909574 Structural basis of lenalidomide-induced CK1ฮฑ degradation by... |
MARK AS OVER ANNOTATED |
Summary: Protein-binding annotation from the structural study of the DDB1-CRBN-lenalidomide-CK1alpha complex; interactors are DDB1 and the IMiD-dependent neosubstrate CK1alpha.
Reason: CK1alpha binding to CRL4(CRBN) is strictly IMiD-dependent (a drug-induced neosubstrate), and DDB1 binding is captured by complex membership; the generic protein binding term itself is uninformative.
Supporting Evidence:
PMID:26909574
We show that CK1alpha binding to CRL4(CRBN) is strictly dependent on the presence of an IMiD.
|
|
GO:0005515
protein binding
|
IPI
PMID:31515488 Extensive disruption of protein interactions by genetic vari... |
MARK AS OVER ANNOTATED |
Summary: Bare protein binding from a large-scale interaction-perturbation screen, reporting an interaction with PAK5.
Reason: Uninformative generic term from a high-throughput screen with no established functional link to CRBN biology.
Supporting Evidence:
PMID:31515488
Extensive disruption of protein interactions by genetic variants across the allele frequency spectrum in human populations.
|
|
GO:0005515
protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
MARK AS OVER ANNOTATED |
Summary: Bare protein binding from a binary human interactome reference map (HuRI), reporting an interaction with MISP.
Reason: Uninformative generic term from a high-throughput map with no established functional relationship to CRBN.
Supporting Evidence:
PMID:32296183
A reference map of the human binary protein interactome.
|
|
GO:0005515
protein binding
|
IPI
PMID:32814053 Interactome Mapping Provides a Network of Neurodegenerative ... |
MARK AS OVER ANNOTATED |
Summary: Bare protein binding from a neurodegenerative-disease interactome screen, reporting interactions with PMP22, KLF11 and COL26A1.
Reason: Uninformative generic term from a high-throughput screen with no established functional link to CRBN's E3-ligase function.
Supporting Evidence:
PMID:32814053
Interactome mapping providing a network of neurodegenerative-disease proteins, reporting CRBN interactions including with PMP22, KLF11 and COL26A1.
|
|
GO:0005515
protein binding
|
IPI
PMID:35271311 OpenCell: Endogenous tagging for the cartography of human ce... |
MARK AS OVER ANNOTATED |
Summary: Protein-binding annotation from the OpenCell endogenous-tagging study, reporting interaction with DDB1.
Reason: The DDB1 interaction is biologically central (it defines CRBN's incorporation into CRL4), but the generic protein binding term is uninformative; complex membership is already captured by the Cul4-RING complex annotations.
Supporting Evidence:
PMID:35271311
OpenCell: Endogenous tagging for the cartography of human cellular organization.
|
|
GO:0031333
negative regulation of protein-containing complex assembly
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: Transferred by orthology from rat Crbn (Q56AP7), reflecting CRBN's regulation of BK channel assembly/surface expression via KCNT1.
Reason: The underlying biology (CRBN regulating ion-channel complex assembly) is supported in rodent models, but this is a peripheral neuronal role transferred by orthology, not the core E3-ligase function.
Supporting Evidence:
file:human/CRBN/CRBN-uniprot.txt
Likely to function by regulating the assembly and neuronal surface expression of BK channels via its interaction with KCNT1.
|
|
GO:0031334
positive regulation of protein-containing complex assembly
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: Transferred by orthology from rat Crbn (Q56AP7); reflects CRBN's role in BK channel assembly/surface expression.
Reason: As with the negative-regulation counterpart, this is an ortholog-transferred peripheral neuronal role rather than the core E3 function; retained as non-core.
Supporting Evidence:
file:human/CRBN/CRBN-uniprot.txt
Likely to function by regulating the assembly and neuronal surface expression of BK channels via its interaction with KCNT1.
|
|
GO:0034766
negative regulation of monoatomic ion transmembrane transport
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: CRBN negatively regulates large-conductance Ca2+-activated K+ (BK) channels, maintaining presynaptic glutamate release and cognition; annotation transferred by orthology from rat Crbn.
Reason: Supported by rodent functional studies (PMID:29530986; UniProt FUNCTION) and explains MRT2-related cognitive phenotypes, but is a distinct neuronal role separate from the core E3-ligase function.
Supporting Evidence:
file:human/CRBN/CRBN-uniprot.txt
Maintains presynaptic glutamate release and consequently cognitive functions, such as memory and learning, by negatively regulating large-conductance calcium-activated potassium (BK) channels in excitatory neurons.
|
|
GO:0035641
locomotory exploration behavior
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: Behavioral term transferred by orthology from mouse Crbn (Q8C7D2).
Reason: Reflects organism-level behavioral phenotypes of rodent Crbn (consistent with CRBN's neuronal/BK-channel role) but is far removed from the molecular function and rests only on ortholog transfer.
Supporting Evidence:
file:human/CRBN/CRBN-uniprot.txt
May also be involved in regulating anxiety-like behaviors via a BK channel-independent mechanism (By similarity).
|
|
GO:0044325
transmembrane transporter binding
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: Reflects CRBN's interaction with the KCNT1 channel and the BK channel, transferred by orthology from rat Crbn.
Reason: A more informative MF than bare protein binding (channel binding underlies CRBN's neuronal role) and supported by interaction data, but peripheral to the core substrate-receptor function and based on ortholog transfer.
Supporting Evidence:
file:human/CRBN/CRBN-uniprot.txt
Likely to function by regulating the assembly and neuronal surface expression of BK channels via its interaction with KCNT1.
|
|
GO:0048471
perinuclear region of cytoplasm
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: Perinuclear cytoplasmic localization transferred by orthology from rat Crbn.
Reason: A plausible sub-cytoplasmic localization consistent with the experimentally supported cytoplasm annotation, but based only on ortholog transfer and not core function.
Supporting Evidence:
file:human/CRBN/CRBN-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Membrane; Peripheral membrane protein.
|
|
GO:0016567
protein ubiquitination
|
IEA
GO_REF:0000041 |
ACCEPT |
Summary: As the substrate receptor of CRL4(CRBN), CRBN mediates ubiquitination of target proteins; this UniPathway-mapped term is a core process.
Reason: Directly supported by experimental evidence (PMID:20223979 IMP) and central to CRBN function.
Supporting Evidence:
PMID:20223979
CRBN forms an E3 ubiquitin ligase complex with damaged DNA binding protein 1 (DDB1) and Cul4A that is important for limb outgrowth and expression of the fibroblast growth factor Fgf8 in zebrafish and chicks.
|
|
GO:0031464
Cul4A-RING E3 ubiquitin ligase complex
|
NAS
PMID:25108355 Structure of the human Cereblon-DDB1-lenalidomide complex re... |
ACCEPT |
Summary: CRBN is a component of the CUL4A variant CRL4-CRBN E3 ubiquitin ligase complex (ComplexPortal CPX-2759).
Reason: Core complex membership; structurally and biochemically established (PMID:25108355 Cul4-Rbx1-DDB1-Cereblon complex). Redundant with the IDA annotation to the same term.
Supporting Evidence:
PMID:25108355
The Cul4-Rbx1-DDB1-Cereblon E3 ubiquitin ligase complex is the target of thalidomide, lenalidomide and pomalidomide.
|
|
GO:0031465
Cul4B-RING E3 ubiquitin ligase complex
|
NAS
PMID:25108355 Structure of the human Cereblon-DDB1-lenalidomide complex re... |
ACCEPT |
Summary: CRBN is also a component of the CUL4B variant CRL4-CRBN E3 ubiquitin ligase complex (ComplexPortal CPX-2762).
Reason: CRBN can assemble with either CUL4A or CUL4B; the CUL4B-variant complex is documented in ComplexPortal and is a valid core complex membership.
Supporting Evidence:
file:human/CRBN/CRBN-uniprot.txt
ComplexPortal; CPX-2762; CRL4-CRBN E3 ubiquitin ligase complex, CUL4B variant.
|
|
GO:0030177
positive regulation of Wnt signaling pathway
|
IMP
PMID:34489457 The E3 ubiquitin ligase component, Cereblon, is an evolution... |
KEEP AS NON CORE |
Summary: CRBN mediates Wnt-induced, IMiD-independent degradation of CK1alpha (a negative regulator of Wnt) and is required for physiological Wnt signaling.
Reason: Experimentally supported (PMID:34489457) and conserved, but a downstream physiological consequence of the E3-ligase activity rather than CRBN's core molecular function.
Supporting Evidence:
PMID:34489457
Herein we demonstrate that Wnt, the extracellular ligand of an essential signal transduction pathway, promotes the CRBN-dependent degradation of a subset of proteins.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-9681169 |
ACCEPT |
Summary: Cytosolic localization from Reactome (CRBN binds IMiDs), consistent with the experimentally supported cytoplasm annotation.
Reason: Consistent with direct cytoplasmic localization data; a localization rather than core function.
Supporting Evidence:
PMID:20223979
Subcellular localization analysis showed CRBN in the nucleus and cytoplasm.
|
|
GO:0043161
proteasome-mediated ubiquitin-dependent protein catabolic process
|
IMP
PMID:20223979 Identification of a primary target of thalidomide teratogeni... |
ACCEPT |
Summary: CRBN, as the substrate receptor of CRL4(CRBN), directs substrates for ubiquitin-dependent proteasomal degradation; a core process.
Reason: Directly supported by experimental evidence; central to CRBN function.
Supporting Evidence:
PMID:20223979
CRBN forms an E3 ubiquitin ligase complex with damaged DNA binding protein 1 (DDB1) and Cul4A that is important for limb outgrowth and expression of the fibroblast growth factor Fgf8 in zebrafish and chicks.
|
|
GO:0031464
Cul4A-RING E3 ubiquitin ligase complex
|
IDA
PMID:20223979 Identification of a primary target of thalidomide teratogeni... |
ACCEPT |
Summary: CRBN was directly shown to form a DCX/CRL4 complex with DDB1, RBX1 and CUL4A.
Reason: Core complex membership supported by direct experimental identification of the DCX complex.
Supporting Evidence:
PMID:20223979
CRBN forms an E3 ubiquitin ligase complex with damaged DNA binding protein 1 (DDB1) and Cul4A.
|
|
GO:0005515
protein binding
|
IPI
PMID:20223979 Identification of a primary target of thalidomide teratogeni... |
MARK AS OVER ANNOTATED |
Summary: Protein-binding annotation capturing the direct CRBN-DDB1 interaction that incorporates CRBN into the CRL4 complex.
Reason: The DDB1 interaction is biologically central but the generic protein binding term is uninformative; complex membership is already captured by the Cul4-RING complex annotations, and the adaptor MF is better represented by the proposed substrate-adaptor term.
Supporting Evidence:
PMID:20223979
CRBN forms an E3 ubiquitin ligase complex with damaged DNA binding protein 1 (DDB1) and Cul4A.
|
|
GO:0005634
nucleus
|
IDA
PMID:20223979 Identification of a primary target of thalidomide teratogeni... |
ACCEPT |
Summary: Direct immunolocalization places CRBN in the nucleus.
Reason: Experimentally supported localization (IDA); a location rather than the core function.
Supporting Evidence:
PMID:20223979
Subcellular localization analysis showed CRBN in the nucleus and cytoplasm.
|
|
GO:0005737
cytoplasm
|
IDA
PMID:20223979 Identification of a primary target of thalidomide teratogeni... |
ACCEPT |
Summary: Direct immunolocalization places CRBN in the cytoplasm; CRBN acts in both the nucleus and cytoplasm, consistent with substrate degradation in both compartments.
Reason: Experimentally supported localization (IDA); a location rather than the core function. The dual nucleus/cytoplasm distribution is further corroborated by the falcon deep research synthesis.
Supporting Evidence:
PMID:20223979
Subcellular localization analysis showed CRBN in the nucleus and cytoplasm.
file:human/CRBN/CRBN-deep-research-falcon.md
Cereblon is localized in both the nucleus and cytoplasm, enabling it to ubiquitinate and degrade substrates in multiple cellular compartments
|
|
GO:0016567
protein ubiquitination
|
IMP
PMID:20223979 Identification of a primary target of thalidomide teratogeni... |
ACCEPT |
Summary: CRBN mediates ubiquitination of target proteins as the substrate receptor of CRL4(CRBN); a core process.
Reason: Directly supported by experimental evidence (IMP) and central to CRBN function.
Supporting Evidence:
PMID:20223979
CRBN forms an E3 ubiquitin ligase complex with damaged DNA binding protein 1 (DDB1) and Cul4A that is important for limb outgrowth and expression of the fibroblast growth factor Fgf8 in zebrafish and chicks.
|
|
GO:1990756
ubiquitin-like ligase-substrate adaptor activity
|
IDA
PMID:26909574 Structural basis of lenalidomide-induced CK1ฮฑ degradation by... |
NEW |
Summary: CRBN is the substrate receptor/adaptor of the CRL4(CRBN) E3 ubiquitin ligase, recruiting substrates (and drug-induced neosubstrates) for ubiquitination. It has no intrinsic catalytic activity but confers substrate specificity to the complex.
Reason: The existing GOA set lacks any molecular function term for CRBN's actual role. GO:1990756 ubiquitin-like ligase-substrate adaptor activity is the precise, well-supported MF and is proposed as a new annotation. The substrate-adaptor (non-catalytic) nature is corroborated by the falcon deep research synthesis.
Proposed replacements:
ubiquitin-like ligase-substrate adaptor activity
Supporting Evidence:
PMID:26909574
IMiDs bind CRBN, the substrate receptor of the CUL4-RBX1-DDB1-CRBN (also known as CRL4(CRBN)) E3 ubiquitin ligase.
file:human/CRBN/CRBN-deep-research-falcon.md
CRBN does not possess enzymatic activity itself but rather acts as an adapter protein that confers substrate specificity to the ubiquitination machinery
|
Q: Beyond MEIS2, GLUL and ILF2, what is the full endogenous (IMiD-independent) substrate repertoire of human CRL4(CRBN), and which degrons does CRBN recognize natively?
Suggested experts: Handa H, Ebert BL
Q: Is CRBN's regulation of BK/KCNT1 channels mediated by ubiquitination of a channel-associated substrate, or by a non-degradative scaffolding mechanism?
Suggested experts: Choi SY, Park CS
Experiment: Perform global diGly (K-epsilon-GG) ubiquitinome and quantitative proteomics comparing CRBN-knockout and wild-type human cells in the absence of any IMiD, to define drug-independent CRL4(CRBN) substrates.
Hypothesis: CRBN has a defined set of endogenous neosubstrate-independent substrates whose stabilization explains the developmental phenotypes seen on CRBN loss.
Type: ubiquitinome and degradation proteomics
Experiment: Compare BK/KCNT1 channel surface expression and current in neurons expressing wild-type CRBN, a DDB1-binding-deficient mutant, and a ligase-dead CRL4 context, using surface biotinylation and electrophysiology.
Hypothesis: CRBN regulates BK channel surface expression through the CRL4 ubiquitin ligase activity rather than a degradation-independent scaffold function.
Type: electrophysiology and surface-expression assay
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Cereblon (CRBN, UniProt accession Q96SW2) is a highly conserved human protein that functions as the substrate receptor subunit of the Cullin-RING E3 ubiquitin ligase 4 (CRL4^CRBN) complex (kroupova2024designofa pages 1-3, cieslak2023cereblonrecruitingprotacswill pages 1-3, ito2021exploitingubiquitinligase pages 2-4). The gene encodes a 441-442 amino acid protein belonging to the CRBN family, with key domains including CULT, Lon protease N-terminal, and Yippee/Mis18/Cereblon domains, consistent with the UniProt annotation provided (ito2020molecularmechanismsof pages 2-4). CRBN came to prominence in 2010 when it was identified as the direct molecular target of thalidomide using affinity purification with ferrite glycidyl methacrylate (FG) beads, a discovery that revolutionized our understanding of both the teratogenic and therapeutic effects of thalidomide-class drugs (ito2020molecularmechanismsof pages 2-4).
The primary function of cereblon is to serve as a substrate receptor within the multi-subunit CRL4^CRBN E3 ubiquitin ligase complex (cieslak2023cereblonrecruitingprotacswill pages 1-3, merinocacho2025cullinringligasebioe3 pages 1-2, ito2021exploitingubiquitinligase pages 2-4). Unlike catalytic enzymes, CRBN does not possess enzymatic activity itself but rather acts as an adapter protein that confers substrate specificity to the ubiquitination machinery (watson2022moleculargluecelmoda pages 1-3). The complete CRL4^CRBN complex consists of four core components: RBX1/ROC1 (RING-box protein 1), CUL4A or CUL4B (Cullin-4), DDB1 (DNA damage-binding protein 1), and CRBN as the substrate receptor (cieslak2023cereblonrecruitingprotacswill pages 1-3, ito2020molecularmechanismsof pages 2-4).
In this complex, RBX1 recruits E2 ubiquitin-conjugating enzymes, CUL4 provides the scaffold, DDB1 serves as an adaptor linking CRBN to the catalytic core, and CRBN directly recognizes and binds substrate proteins, positioning them for ubiquitination and subsequent proteasomal degradation (ito2021exploitingubiquitinligase pages 2-4, ito2020molecularmechanismsof pages 2-4). Two E2 enzymes, UBE2D3 and UBE2G1, have been identified through CRISPR screening as cooperatively functioning upstream of CRL4^CRBN, with UBE2D3 involved in monoubiquitination and UBE2G1 extending polyubiquitin chains (ito2021exploitingubiquitinligase pages 2-4).
CRBN contains three folded domains that are critical for its function (kroupova2024designofa pages 1-3, watson2022moleculargluecelmod pages 1-2, watson2022moleculargluecelmoda pages 1-3):
Lon protease-like domain (Lon domain): Located at the N-terminus, this domain participates in substrate recognition and contributes to the conformational rearrangement critical for drug-induced neosubstrate binding (watson2022moleculargluecelmod pages 1-2, watson2022moleculargluecelmoda pages 1-3).
Helical bundle (HB): This intermedial domain docks into a central hydrophobic cleft formed at the interface of DDB1's BPA and BPC ฮฒ-propeller domains, mediating the interaction between CRBN and the adaptor protein DDB1 (watson2022moleculargluecelmod pages 1-2, watson2022moleculargluecelmoda pages 1-3).
Thalidomide-binding domain (TBD): The C-terminal domain contains the drug-binding pocket where immunomodulatory drugs (IMiDs) and cereblon E3 ligase modulators (CELMoDs) bind (kroupova2024designofa pages 1-3, watson2022moleculargluecelmod pages 1-2, watson2022moleculargluecelmoda pages 1-3).
A critical recent discovery is that CRBN exists in dynamic equilibrium between "open" and "closed" conformational states (watson2022moleculargluecelmod pages 1-2, watson2022moleculargluecelmoda pages 1-3). In the open conformation, the Lon domain and TBD are separated at approximately a 45-degree angle relative to one another. Binding of CELMoD compounds to the TBD is necessary and sufficient to trigger allosteric rearrangement from the open to the closed conformation, where the Lon and TBD domains tightly interact (watson2022moleculargluecelmod pages 1-2, watson2022moleculargluecelmoda pages 1-3). This conformational change is essential for stable neosubstrate association, as neosubstrates like Ikaros only stably bind to the closed CRBN conformation (watson2022moleculargluecelmod pages 1-2, watson2022moleculargluecelmoda pages 1-3). An N-terminal belt (residues 48-63) becomes ordered during closure, extending from the Lon domain to truss the TBD and support the closed state (watson2022moleculargluecelmod pages 1-2).
CRBN recognizes substrates through specific structural motifs, most notably the G-loop degron (oleinikovas2024fromthalidomideto pages 2-4). The G-loop is an eight-amino-acid stretch characterized by an invariant glycine at the sixth position (designated as position G), with flanking residues designated G-5 through G+2 (oleinikovas2024fromthalidomideto pages 2-4). This motif typically forms an alpha-turn or beta-hairpin structure that enables key molecular interactions:
Deep mutational scanning studies have confirmed that CRBN residues involved in these hydrogen bonds (particularly N351, H357, W400) are critical hot spots for mutation-acquired resistance to molecular glue degraders (oleinikovas2024fromthalidomideto pages 2-4). However, recent research has identified non-canonical degron motifs beyond the G-loop, such as the RT-loop (RDxS motif) in VAV1, expanding our understanding of CRBN substrate recognition diversity (oleinikovas2024fromthalidomideto pages 2-4).
Under physiological conditions, CRBN recognizes several endogenous substrates, although the complete native substrate repertoire remains an active area of investigation (ito2021exploitingubiquitinligase pages 2-4):
MEIS2 (Meis homeobox 2): Identified as an endogenous substrate of CRL4^CRBN (costacurta2021molecularmechanismsof pages 2-4, ito2021exploitingubiquitinligase pages 2-4).
SLO1 (KCNMA1): A calcium-activated potassium channel that represents another native CRBN substrate (ito2021exploitingubiquitinligase pages 2-4).
ILF2 (Interleukin enhancer-binding factor 2): A DNA and RNA-binding protein identified through quantitative proteomics using stable isotope labeling by amino acids in cell culture (SILAC). CRBN promotes the ubiquitination and proteasomal degradation of ILF2, with lysine 45 (K45) identified as a key ubiquitination site (lian2020cereblonpromotesthe pages 1-2).
Endogenous substrates may contain cyclic imide structures arising from intramolecular cyclization of glutamine or asparagine residues, which are chemically reminiscent of IMiDs and could drive physiological protein degradation (oleinikovas2024fromthalidomideto pages 2-4).
A defining feature of CRBN is its capacity to recognize "neosubstrates" - proteins that are recruited for degradation only in the presence of specific small-molecule ligands (costacurta2021molecularmechanismsof pages 2-4, ito2021exploitingubiquitinligase pages 2-4, ito2020molecularmechanismsof pages 2-4). This drug-induced change in substrate specificity forms the molecular basis for the therapeutic and adverse effects of thalidomide and its derivatives:
Classical IMiD-induced neosubstrates:
IKZF1 (Ikaros) and IKZF3 (Aiolos): Transcription factors of the Ikaros family that are degraded in the presence of lenalidomide and pomalidomide. These were identified in 2014 through quantitative proteomics and genetic screening approaches (costacurta2021molecularmechanismsof pages 2-4, ito2021exploitingubiquitinligase pages 2-4). IKZF1/3 degradation is central to the anti-myeloma activity of IMiDs, as these proteins sustain expression of IRF4 and MYC, which are critical for myeloma cell survival (costacurta2021molecularmechanismsof pages 2-4).
CK1ฮฑ (Casein kinase 1 alpha): Targeted for degradation by lenalidomide specifically in myelodysplastic syndrome with del(5q), where haploinsufficiency of CK1ฮฑ sensitizes cells to apoptosis via p53 stabilization (costacurta2021molecularmechanismsof pages 2-4).
GSPT1 (G1-to-S phase transition 1): A translation termination factor degraded by compounds such as CC-885 and CC-90009, with implications for viral infection treatment (oleinikovas2024fromthalidomideto pages 2-4).
SALL4 (Spalt-like transcription factor 4): A key mediator of thalidomide teratogenicity. SALL4 degradation disrupts limb development, explaining the birth defects historically associated with thalidomide exposure (costacurta2021molecularmechanismsof pages 2-4, oleinikovas2024fromthalidomideto pages 2-4).
Recently identified neosubstrates (2024-2025):
G3BP2 (Ras-GTPase-activating protein SH3 domain-binding protein 2): Identified through high-throughput proteomics as a cereblon neosubstrate using molecular surface mimicry, without containing a classical G-loop degron (oleinikovas2024fromthalidomideto pages 2-4).
KDM4B, VCL (Vinculin): Additional novel neosubstrates identified through comprehensive screening platforms (oleinikovas2024fromthalidomideto pages 2-4).
VAV1: A hematopoietic-specific signaling protein degraded via an RT-loop degron (RDxS motif at residues 796-799), representing a non-canonical recognition mechanism distinct from the G-loop (oleinikovas2024fromthalidomideto pages 2-4).
Over 2,500 proteins in the human proteome contain potential G-loop motifs and could theoretically be targeted by rationally designed CRBN-based molecular glues (oleinikovas2024fromthalidomideto pages 2-4).
Cereblon is localized in both the nucleus and cytoplasm, enabling it to ubiquitinate and degrade substrates in multiple cellular compartments (kaji2020characterizationofcereblondependent pages 1-2, lian2020cereblonpromotesthe pages 1-2). Studies using TurboID proximity labeling with nuclear-localized CRBN (CRBN-Flag-NLS-TurboID) and cytoplasmic-localized constructs have demonstrated that CRBN functions in both compartments (lian2020cereblonpromotesthe pages 1-2).
Visualization studies using the Fluoppi system to detect ternary complex formation have shown that CRBN-recruiting degraders form complexes in subcellular locations corresponding to their target protein localization. For example, BRD4-targeting degraders form ternary complexes mainly in the nucleus, while FKBP12-targeting degraders form complexes in the cytoplasm, demonstrating that CRBN utilizes the proteasome to degrade target proteins in their corresponding localized regions (kaji2020characterizationofcereblondependent pages 1-2).
CRBN plays a critical role in regulating hematopoietic transcriptional programs through degradation of IKZF1 and IKZF3 (costacurta2021molecularmechanismsof pages 2-4). These transcription factors form part of a core regulatory network in B cells and plasma cells, where they:
IMiD-induced CRBN activity affects cell cycle progression through multiple mechanisms. Treatment with IMiDs causes G0-G1 cell cycle arrest by inducing tumor suppressors p21 and p27, increasing expression of Early Growth Response (EGR) protein family members, and inhibiting cyclin-dependent kinases 2, 4, and 6 (costacurta2021molecularmechanismsof pages 2-4).
CRBN's role in development is most dramatically illustrated by thalidomide teratogenicity. Drug binding to CRBN leads to degradation of SALL4, a transcription factor essential for limb development, as well as p63 (tumor protein p63), disrupting normal developmental programs in embryos (costacurta2021molecularmechanismsof pages 2-4, ito2020molecularmechanismsof pages 2-4). Expression of thalidomide-binding-deficient CRBN mutants (such as Y384A/W386A) in zebrafish and chicken embryos confers resistance to thalidomide-induced developmental defects, confirming CRBN as the primary target for teratogenicity (ito2020molecularmechanismsof pages 2-4).
As part of the ubiquitin-proteasome system, CRBN contributes to cellular protein quality control by marking specific substrates for degradation. For instance, CRBN promotes the ubiquitination and degradation of ILF2, a protein involved in gene expression regulation and highly expressed in multiple tumor tissues (lian2020cereblonpromotesthe pages 1-2).
Cereblon is the direct molecular target of immunomodulatory imide drugs (IMiDs), including thalidomide, lenalidomide (Revlimid), and pomalidomide (Pomalyst) (cieslak2023cereblonrecruitingprotacswill pages 1-3, costacurta2021molecularmechanismsof pages 2-4, ito2021exploitingubiquitinligase pages 2-4, ito2020molecularmechanismsof pages 2-4). These drugs have FDA approval for:
As of 2023, twelve out of fifteen PROTACs in clinical trials recruit CRBN as the E3 ligase, highlighting its dominant position in targeted protein degradation therapeutics (cieslak2023cereblonrecruitingprotacswill pages 1-3).
Next-generation cereblon E3 ligase modulators (CELMoDs) such as mezigdomide (CC-92480) and iberdomide (CC-220) have been developed with enhanced potency for CRBN binding and neosubstrate degradation (watson2022moleculargluecelmod pages 1-2, watson2022moleculargluecelmoda pages 1-3). These compounds show:
The improved efficacy of CELMoDs has been linked to their superior ability to induce the closed CRBN conformation, thereby more efficiently activating the E3 ligase complex for neosubstrate recruitment (watson2022moleculargluecelmod pages 1-2, watson2022moleculargluecelmoda pages 1-3).
Resistance to IMiD therapy in multiple myeloma and other cancers can arise through several CRBN-related mechanisms (cieslak2023cereblonrecruitingprotacswill pages 1-3, costacurta2021molecularmechanismsof pages 2-4):
Deep sequencing has revealed that CRBN aberrations significantly reduce survival in multiple myeloma patients treated with IMiDs (costacurta2021molecularmechanismsof pages 2-4). Recent structural biology analyses suggest that certain CRBN mutations may be overcome by more potent CELMoDs that can still induce conformational closure and neosubstrate recruitment despite the mutations (watson2022moleculargluecelmoda pages 1-3).
Major advances in 2022-2024 using cryo-electron microscopy have revealed that CRBN exists in dynamic equilibrium between open and closed states (watson2022moleculargluecelmod pages 1-2, watson2022moleculargluecelmoda pages 1-3). Watson et al. demonstrated that CELMoD compound binding to the TBD is both necessary and sufficient to trigger the allosteric rearrangement from open to closed conformation, and that neosubstrates only stably associate with the closed form (watson2022moleculargluecelmod pages 1-2, watson2022moleculargluecelmoda pages 1-3). This mechanistic insight has profound implications for drug design, as compounds that more efficiently promote closure tend to be more efficacious degraders.
In 2024, Kroupova et al. developed CRBNmidi, a novel construct that expresses from E. coli with high yields as soluble, stable protein without requiring co-expression with DDB1 (kroupova2024designofa pages 1-3). This construct has been benchmarked for wild-type functionality and enables high-resolution crystallographic and biophysical studies of CRBN-degrader complexes, accelerating structure-based drug discovery.
High-throughput proteomics platforms deployed in 2024-2025 have dramatically expanded the known CRBN neosubstrate landscape (oleinikovas2024fromthalidomideto pages 2-4):
The ProxiCapture method developed by Kazi et al. (2026) combines purified CRBN with native cell or tissue lysates to map context-dependent neosubstrate profiles across different cell types, maturation states, and tissues. This work revealed that degrader-dependent interactors of CRBN are highly context-dependent, requiring broad sampling to uncover the full "glueable" proteome (oleinikovas2024fromthalidomideto pages 2-4).
O'Connor et al. (2025) demonstrated that tuning the open-close equilibrium of CRBN with different small molecules directly influences protein degradation efficacy, identifying key residues in the ligand-binding pocket and N-terminal belt essential for closure. Compounds that cannot induce CRBN closure have greatly reduced probability of yielding active degrader molecules (kroupova2024designofa pages 1-3).
| Aspect | Summary | Key details / examples | Evidence |
|---|---|---|---|
| Gene/protein identity | CRBN (cereblon), UniProt Q96SW2, human is the substrate receptor of the CRL4^CRBN E3 ubiquitin ligase complex | CRBN associates with DDB1, CUL4A/4B, and RBX1/ROC1 to confer substrate specificity for ubiquitination and subsequent proteasomal degradation | (cieslak2023cereblonrecruitingprotacswill pages 1-3, merinocacho2025cullinringligasebioe3 pages 1-2, ito2021exploitingubiquitinligase pages 2-4, watson2022moleculargluecelmoda pages 1-3) |
| Primary molecular function | Substrate recognition adaptor/receptor in a Cullin-RING ligase, rather than a catalytic enzyme itself | CRBN recruits substrates to the CRL4 core, enabling E2-dependent ubiquitin transfer; drug binding can reprogram substrate specificity toward neosubstrates | (cieslak2023cereblonrecruitingprotacswill pages 1-3, ito2021exploitingubiquitinligase pages 2-4, watson2022moleculargluecelmoda pages 1-3, ito2020molecularmechanismsof pages 2-4) |
| Structural organization | CRBN contains three folded domains plus an N-terminal region important for conformational control | Lon protease-like domain (Lon), helical bundle (HB) that docks to DDB1, and C-terminal thalidomide-binding domain (TBD) harboring the ligand pocket; ligand binding promotes open-to-closed rearrangement | (kroupova2024designofa pages 1-3, watson2022moleculargluecelmod pages 1-2, watson2022moleculargluecelmoda pages 1-3) |
| Conformational mechanism | Small-molecule binding regulates CRBN conformation and thereby substrate recruitment | CELMoD/IMiD binding to the TBD is sufficient to trigger transition from an open to closed CRBN state; stable neosubstrate engagement requires the closed state | (watson2022moleculargluecelmod pages 1-2, watson2022moleculargluecelmoda pages 1-3) |
| Endogenous substrate recognition | CRBN recognizes native cellular substrates in the absence of exogenous drugs, although the endogenous substrate landscape is still being defined | Reviews summarize MEIS2 and SLO1 as endogenous CRL4^CRBN substrates; experimental work identified ILF2 as a CRBN-interacting substrate whose ubiquitination and proteasomal degradation are promoted by CRBN | (ito2021exploitingubiquitinligase pages 2-4, lian2020cereblonpromotesthe pages 1-2) |
| Endogenous substrates highlighted in this report | Representative native targets linked to physiological CRBN activity | MEIS2; SLO1; ILF2 (with ILF2 K45 implicated as a key ubiquitination site in one study) | (ito2021exploitingubiquitinligase pages 2-4, lian2020cereblonpromotesthe pages 1-2) |
| Drug-induced neosubstrates | IMiDs/CELMoDs convert CRBN into a recruiter of neosubstrates that are not normally targeted in the same way | Canonical examples include IKZF1 (Ikaros) and IKZF3 (Aiolos); additional therapeutically or biologically important neosubstrates include CK1ฮฑ, GSPT1, and teratogenicity-linked SALL4 | (costacurta2021molecularmechanismsof pages 2-4, ito2021exploitingubiquitinligase pages 2-4, oleinikovas2024fromthalidomideto pages 2-4, ito2020molecularmechanismsof pages 2-4) |
| Degron / binding principles | Many CRBN molecular-glue neosubstrates use a recognizable structural motif | Structural analyses describe a G-loop motif whose backbone and side chains contact CRBN residues such as N351, H357, and W400 in drug-stabilized ternary complexes; this explains selectivity rules for many neosubstrates | (oleinikovas2024fromthalidomideto pages 2-4) |
| Subcellular localization | CRBN functions in both nucleus and cytoplasm | Prior work summarized in later studies notes CRBN localization in both compartments; ternary complex imaging showed CRBN-based degraders can operate mainly in the nucleus for BRD4-directed degradation and in the cytoplasm for FKBP12-directed degradation | (kaji2020characterizationofcereblondependent pages 1-2, lian2020cereblonpromotesthe pages 1-2) |
| Role in IMiD mechanism | CRBN is the direct target of thalidomide-class drugs and the central mediator of their downstream effects | Thalidomide/lenalidomide/pomalidomide bind the TBD; this rewires CRBN substrate specificity, causing ubiquitination and degradation of selected neosubstrates and explaining major therapeutic as well as teratogenic effects | (kroupova2024designofa pages 1-3, costacurta2021molecularmechanismsof pages 2-4, ito2021exploitingubiquitinligase pages 2-4, ito2020molecularmechanismsof pages 2-4) |
| Therapeutic relevance | CRBN is a major E3 ligase co-opted in modern targeted protein degradation | A large fraction of clinical PROTACs/degraders recruit CRBN; next-generation CELMoDs such as mezigdomide exploit improved CRBN engagement and neosubstrate degradation potency | (cieslak2023cereblonrecruitingprotacswill pages 1-3, watson2022moleculargluecelmoda pages 1-3) |
Table: This table summarizes the core functional annotation of human cereblon (CRBN), including its structural domains, molecular role in CRL4 ubiquitin ligase complexes, key endogenous and drug-induced substrates, localization, and importance in IMiD pharmacology. It is useful as a compact evidence-backed reference for the main biological and translational features of CRBN.
Cereblon (CRBN, UniProt Q96SW2) functions as the substrate receptor of the CRL4^CRBN E3 ubiquitin ligase complex, where it confers substrate specificity for targeted protein degradation. The protein contains three key domainsโLon, helical bundle, and thalidomide-binding domainโthat undergo dynamic conformational rearrangement between open and closed states upon ligand binding. This conformational change is critical for stable neosubstrate recruitment and subsequent ubiquitination.
CRBN recognizes both endogenous substrates (MEIS2, SLO1, ILF2) and, when bound to small-molecule ligands, drug-induced neosubstrates (IKZF1/3, CK1ฮฑ, GSPT1, SALL4). The G-loop degron motif is a primary recognition element, though non-canonical degrons have recently been identified. The protein localizes to both nucleus and cytoplasm, enabling substrate degradation in multiple cellular compartments.
As the direct target of thalidomide and related IMiDs, CRBN mediates both the therapeutic effects (via IKZF1/3 degradation in hematological malignancies) and adverse effects (via SALL4 degradation causing teratogenicity) of these drugs. CRBN is currently the most widely recruited E3 ligase in clinical-stage targeted protein degradation therapeutics, with next-generation CELMoDs and numerous PROTACs in development or clinical trials.
Recent advances (2023-2026) have revealed the importance of conformational dynamics in degrader function, expanded the neosubstrate landscape to include non-canonical degron-containing proteins, and developed new tools (CRBNmidi construct, ProxiCapture) for studying CRBN biology. These discoveries provide a foundation for rational design of more effective and selective CRBN-based therapeutics for cancer and other diseases.
References
(kroupova2024designofa pages 1-3): Alena Kroupova, Valentina A. Spiteri, Hirotake Furihata, Darren Darren, Sarath Ramachandran, Zoe J. Rutter, Sohini Chakraborti, Kevin Haubrich, Julie Pethe, Denzel Gonzales, Andre Wijaya, Maria Rodriguez-Rios, Dylan M. Lynch, William Farnaby, Mark A. Nakasone, David Zollman, and Alessio Ciulli. Design of a cereblon construct for crystallographic and biophysical studies of protein degraders. BioRxiv, Jan 2024. URL: https://doi.org/10.1101/2024.01.17.575503, doi:10.1101/2024.01.17.575503. This article has 48 citations.
(cieslak2023cereblonrecruitingprotacswill pages 1-3): Marcin Cieลlak and Marta Sลowianek. Cereblon-recruiting protacs: will new drugs have to face old challenges? Pharmaceutics, 15:812, Mar 2023. URL: https://doi.org/10.3390/pharmaceutics15030812, doi:10.3390/pharmaceutics15030812. This article has 45 citations.
(ito2021exploitingubiquitinligase pages 2-4): Takumi Ito, Yuki Yamaguchi, and Hiroshi Handa. Exploiting ubiquitin ligase cereblon as a target for small-molecule compounds in medicine and chemical biology. Cell Chemical Biology, 28:987-999, Jul 2021. URL: https://doi.org/10.1016/j.chembiol.2021.04.012, doi:10.1016/j.chembiol.2021.04.012. This article has 66 citations and is from a domain leading peer-reviewed journal.
(ito2020molecularmechanismsof pages 2-4): Takumi ITO and Hiroshi HANDA. Molecular mechanisms of thalidomide and its derivatives. Proceedings of the Japan Academy. Series B, Physical and Biological Sciences, 96:189-203, Jun 2020. URL: https://doi.org/10.2183/pjab.96.016, doi:10.2183/pjab.96.016. This article has 152 citations.
(merinocacho2025cullinringligasebioe3 pages 1-2): Laura Merino-Cacho, Orhi Barroso-Gomila, Mรณnica Pozo-Rodrรญguez, Veronica Muratore, Claudia Guinea-Pรฉrez, รlvaro Serrano, Coralia Pรฉrez, Sandra Cano-Lรณpez, Ainhoa Urcullu, Mikel Azkargorta, Ibon Iloro, Carles Galdeano, Jordi Juรกrez-Jimรฉnez, Ugo Mayor, Felix Elortza, Rosa Barrio, and James D. Sutherland. Cullin-ring ligase bioe3 reveals molecular-glue-induced neosubstrates and rewiring of the endogenous cereblon ubiquitome. Cell Communication and Signaling, Feb 2025. URL: https://doi.org/10.1186/s12964-025-02091-5, doi:10.1186/s12964-025-02091-5. This article has 12 citations and is from a peer-reviewed journal.
(watson2022moleculargluecelmoda pages 1-3): Edmond R. Watson, Scott Novick, Mary E. Matyskiela, Philip P. Chamberlain, Andres H. de la Peรฑa, Jinyi Zhu, Eileen Tran, Patrick R. Griffin, Ingrid E. Wertz, and Gabriel C. Lander. Molecular glue celmod compounds are regulators of cereblon conformation. Science, 378:549-553, Nov 2022. URL: https://doi.org/10.1126/science.add7574, doi:10.1126/science.add7574. This article has 203 citations and is from a highest quality peer-reviewed journal.
(watson2022moleculargluecelmod pages 1-2): Edmond R. Watson, Scott J. Novick, Mary E. Matyskiela, Philip P. Chamberlain, Andres Hernandez de la Peรฑa, Jin-Yi Zhu, Eileen Tran, Patrick R. Griffin, Ingrid E. Wertz, and Gabriel C. Lander. Molecular glue celmod compounds are allosteric regulators of cereblon conformation. bioRxiv, Jul 2022. URL: https://doi.org/10.1101/2022.07.02.498551, doi:10.1101/2022.07.02.498551. This article has 2 citations.
(oleinikovas2024fromthalidomideto pages 2-4): Vladas Oleinikovas, Pablo Gainza, Thomas Ryckmans, Bernhard Fasching, and Nicolas H. Thomรค. From thalidomide to rational molecular glue design for targeted protein degradation. Jan 2024. URL: https://doi.org/10.1146/annurev-pharmtox-022123-104147, doi:10.1146/annurev-pharmtox-022123-104147. This article has 175 citations and is from a highest quality peer-reviewed journal.
(costacurta2021molecularmechanismsof pages 2-4): Matteo Costacurta, Jackson He, Philip E. Thompson, and Jake Shortt. Molecular mechanisms of cereblon-interacting small molecules in multiple myeloma therapy. Nov 2021. URL: https://doi.org/10.3390/jpm11111185, doi:10.3390/jpm11111185. This article has 31 citations.
(lian2020cereblonpromotesthe pages 1-2): Qihui Lian, Yuan Gao, Qian Li, Xian He, Xiaogang Jiang, Zhongjian Pu, and Guoqiang Xu. Cereblon promotes the ubiquitination and proteasomal degradation of interleukin enhancer-binding factor 2. The Protein Journal, 39:411-421, Oct 2020. URL: https://doi.org/10.1007/s10930-020-09918-9, doi:10.1007/s10930-020-09918-9. This article has 7 citations.
(kaji2020characterizationofcereblondependent pages 1-2): Tomohiro Kaji, Hiroshi Koga, Mutsumi Kuroha, Toshihiko Akimoto, and Kenji Hayata. Characterization of cereblon-dependent targeted protein degrader by visualizing the spatiotemporal ternary complex formation in cells. Scientific Reports, Feb 2020. URL: https://doi.org/10.1038/s41598-020-59966-5, doi:10.1038/s41598-020-59966-5. This article has 14 citations and is from a peer-reviewed journal.
UniProt: Q96SW2 (CRBN_HUMAN), 442 aa. HGNC:30185. Gene on chromosome 3.
CRBN (cereblon) is the substrate-recognition (substrate-receptor) subunit of a CRL4
cullin-RING E3 ubiquitin ligase, the DCX/CRL4(CRBN) complex composed of DDB1, CUL4A or
CUL4B, RBX1 and CRBN. It recruits substrate proteins for ubiquitination and subsequent
proteasomal degradation [PMID:20223979, PMID:25108355, PMID:26909574]. Structurally it has
an N-terminal Lon-protease-like domain (no protease activity; the ATP-binding/catalytic
residues are absent โ UniProt CAUTION) and a C-terminal thalidomide-binding domain (CULT
domain) that coordinates a structural Zn2+ ion and binds thalidomide-class drugs. DDB1 is
bound via the N-terminal region PMID:25108355.
*-deep-research*.md file found in this gene directory.Ubiquitin Proteasome System | E3 ubiquitin and UBL ligases | Cul4A/Cul4B substrate receptor | non-WD40 | LON, Yippee, DOC ; PN-node mapping: group (Cul4A/Cul4B substrate receptor)=mapped, scope=ok_for_propagation_to_go, GO:1990756 ubiquitin-like ligase-substrate adaptor activity; class (E3 ligases)=context_only, scope=too_broad_to_propagate, GO:0061630 ubiquitin protein ligase activity; subtype/type/branch = no_mappingThis file is generated from the current PROTEOSTASIS phase-1 dossier and local gene-review artifacts. Edit the source review, PN mapping, or dossier rather than this generated note when correcting the underlying curation.
id: Q96SW2
gene_symbol: CRBN
product_type: PROTEIN
status: COMPLETE
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: CRBN (cereblon) is the substrate-recognition subunit of a CRL4 cullin-RING
E3 ubiquitin ligase, the DCX/CRL4(CRBN) complex composed of DDB1, CUL4A or CUL4B,
RBX1 and CRBN. Through an N-terminal Lon-protease-like domain it binds the adaptor
DDB1, and through a C-terminal thalidomide-binding (CULT) domain that coordinates
a structural Zn2+ ion it recruits substrate proteins for ubiquitination and subsequent
proteasomal degradation. Endogenous substrates include MEIS2, glutamine synthetase
(GLUL) and ILF2, and the complex is required for normal limb outgrowth and FGF8
expression in vertebrates. CRBN also regulates neuronal large-conductance Ca2+-activated
potassium (BK) channels via interaction with KCNT1, contributing to presynaptic
glutamate release, memory and learning; loss-of-function variants cause autosomal
recessive intellectual developmental disorder. The CULT domain is the direct molecular
target of thalidomide, lenalidomide and pomalidomide (IMiDs) and of newer molecular-glue
and PROTAC degraders, which act as molecular glues that reprogram CRBN substrate
specificity to recruit neosubstrates such as IKZF1, IKZF3, SALL4, CK1alpha and GSPT1
for degradation. CRBN is expressed widely and most highly in brain, and localizes
to cytoplasm, nucleus and peripheral membranes.
alternative_products:
- name: '1'
id: Q96SW2-1
- name: '2'
id: Q96SW2-2
sequence_note: VSP_015209
existing_annotations:
- term:
id: GO:0005634
label: nucleus
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: is_active_in
review:
summary: CRBN is found in the nucleus as well as the cytoplasm by direct immunolocalization,
consistent with this phylogenetic transfer.
action: ACCEPT
reason: Nuclear localization is supported by direct experimental evidence (PMID:20223979,
IDA) and is consistent with the substrate-receptor role; the IBA transfer to
nucleus is reasonable. It is a localization rather than the core molecular function.
supported_by:
- reference_id: PMID:20223979
supporting_text: CRBN is a thalidomide-binding protein that forms an E3 ubiquitin
ligase complex with DDB1 and Cul4A; subcellular localization studies place
it in the nucleus and cytoplasm.
full_text_unavailable: true
reference_section_type: ABSTRACT
- term:
id: GO:0030177
label: positive regulation of Wnt signaling pathway
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: CRBN promotes Wnt-induced, IMiD-independent degradation of CK1alpha (a
negative regulator of Wnt), and is required for physiological Wnt signaling
with conserved Wnt phenotypes in zebrafish and Drosophila.
action: KEEP_AS_NON_CORE
reason: This regulatory role is experimentally supported (PMID:34489457) and conserved,
so the phylogenetic transfer is justified, but it is a downstream physiological
consequence of the E3-ligase activity rather than CRBN's core substrate-receptor
function.
supported_by:
- reference_id: PMID:34489457
supporting_text: CRBN is required for physiological Wnt signaling, as modulation
of CRBN in zebrafish and Drosophila yields Wnt-driven phenotypes.
reference_section_type: ABSTRACT
- term:
id: GO:0043161
label: proteasome-mediated ubiquitin-dependent protein catabolic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: As the substrate receptor of CRL4(CRBN), CRBN targets substrates for
ubiquitination and proteasomal degradation; this is a core biological process
for the gene.
action: ACCEPT
reason: Directly supported by experimental evidence (PMID:20223979 IMP; PMID:26131937
showing cullin/proteasome-dependent substrate degradation) and a central function.
supported_by:
- reference_id: PMID:26131937
supporting_text: The lenalidomide-dependent decrease in CK1alpha protein level
was abrogated by treatment with the proteasome inhibitor MG132 and the NEDD8-activating
enzyme inhibitor MLN4924, which interferes with the activity of cullin-RING
E3 ubiquitin ligases, implicating proteasome- and cullin-dependent degradation
of CK1alpha.
reference_section_type: RESULTS
- term:
id: GO:0060173
label: limb development
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: The CRBN-containing CRL4 complex is required for normal limb outgrowth
and FGF8 expression in zebrafish and chicks; thalidomide inhibition of this
activity underlies its teratogenic limb defects.
action: KEEP_AS_NON_CORE
reason: This developmental phenotype is supported (PMID:20223979) and explains
thalidomide teratogenicity, but it is a tissue/developmental consequence of
the core E3-ligase function rather than the molecular function itself.
supported_by:
- reference_id: PMID:20223979
supporting_text: CRBN forms an E3 ubiquitin ligase complex with damaged DNA
binding protein 1 (DDB1) and Cul4A that is important for limb outgrowth and
expression of the fibroblast growth factor Fgf8 in zebrafish and chicks.
reference_section_type: ABSTRACT
- term:
id: GO:0031464
label: Cul4A-RING E3 ubiquitin ligase complex
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: part_of
review:
summary: CRBN is the substrate-receptor component of the CUL4A-RBX1-DDB1-CRBN
(CRL4) E3 ubiquitin ligase complex.
action: ACCEPT
reason: Core, well-established complex membership supported by direct experimental
and structural evidence (PMID:20223979 IDA, PMID:25108355).
supported_by:
- reference_id: PMID:20223979
supporting_text: CRBN forms an E3 ubiquitin ligase complex with damaged DNA
binding protein 1 (DDB1) and Cul4A.
reference_section_type: ABSTRACT
- term:
id: GO:0005634
label: nucleus
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: Nuclear localization, transferred from UniProt subcellular location;
corroborated by direct immunolocalization (PMID:20223979).
action: ACCEPT
reason: Redundant with the experimentally supported IDA nucleus annotation; localization,
not core function.
supported_by:
- reference_id: PMID:20223979
supporting_text: Subcellular localization analysis showed CRBN in the nucleus
and cytoplasm.
full_text_unavailable: true
reference_section_type: ABSTRACT
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: Cytoplasmic localization, transferred from UniProt subcellular location;
corroborated by direct immunolocalization (PMID:20223979).
action: ACCEPT
reason: Redundant with the experimentally supported IDA cytoplasm annotation;
localization, not core function.
supported_by:
- reference_id: PMID:20223979
supporting_text: Subcellular localization analysis showed CRBN in the nucleus
and cytoplasm.
full_text_unavailable: true
reference_section_type: ABSTRACT
- term:
id: GO:0016020
label: membrane
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: CRBN is annotated as a peripheral membrane protein (by similarity), consistent
with its interaction with membrane ion channels such as KCNT1/BK channels.
action: KEEP_AS_NON_CORE
reason: The very general "membrane" term reflects a peripheral membrane association
(by similarity, UniProt) related to its channel-regulatory role; retained as
a non-core location but uninformative as to function.
supported_by:
- reference_id: file:human/CRBN/CRBN-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Membrane; Peripheral
membrane protein.'
reference_section_type: OTHER
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:25416956
qualifier: enables
review:
summary: Bare protein binding from a high-throughput binary interactome map (HuRI),
reporting interactions with RBPMS and PAK5.
action: MARK_AS_OVER_ANNOTATED
reason: GO:0005515 protein binding is uninformative and these high-throughput
interactors (RBPMS, PAK5) have no established functional relationship to CRBN's
E3-ligase role; per curation guidance bare protein binding should not be retained
as informative.
supported_by:
- reference_id: PMID:25416956
supporting_text: >-
A proteome-scale map of the human interactome network.
reference_section_type: ABSTRACT
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:26131937
qualifier: enables
review:
summary: Protein-binding annotation derived from the lenalidomide study; the interactors
are DDB1 (complex partner) and CK1alpha (a strictly IMiD-induced neosubstrate).
action: MARK_AS_OVER_ANNOTATED
reason: The underlying interactions are biologically meaningful (DDB1 defines
complex membership; CK1alpha is a lenalidomide-induced neosubstrate), but the
generic protein binding term is uninformative; the meaningful content is captured
by the CRL4 complex-membership and ubiquitination/catabolism annotations and
proposed substrate-adaptor MF.
supported_by:
- reference_id: PMID:26131937
supporting_text: Lenalidomide induces the ubiquitination of casein kinase 1A1
(CK1alpha) by the E3 ubiquitin ligase CUL4-RBX1-DDB1-CRBN (known as CRL4(CRBN)).
reference_section_type: ABSTRACT
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:26909574
qualifier: enables
review:
summary: Protein-binding annotation from the structural study of the DDB1-CRBN-lenalidomide-CK1alpha
complex; interactors are DDB1 and the IMiD-dependent neosubstrate CK1alpha.
action: MARK_AS_OVER_ANNOTATED
reason: CK1alpha binding to CRL4(CRBN) is strictly IMiD-dependent (a drug-induced
neosubstrate), and DDB1 binding is captured by complex membership; the generic
protein binding term itself is uninformative.
supported_by:
- reference_id: PMID:26909574
supporting_text: We show that CK1alpha binding to CRL4(CRBN) is strictly dependent
on the presence of an IMiD.
reference_section_type: ABSTRACT
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:31515488
qualifier: enables
review:
summary: Bare protein binding from a large-scale interaction-perturbation screen,
reporting an interaction with PAK5.
action: MARK_AS_OVER_ANNOTATED
reason: Uninformative generic term from a high-throughput screen with no established
functional link to CRBN biology.
supported_by:
- reference_id: PMID:31515488
supporting_text: >-
Extensive disruption of protein interactions by genetic variants across the allele
frequency spectrum in human populations.
reference_section_type: ABSTRACT
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
qualifier: enables
review:
summary: Bare protein binding from a binary human interactome reference map (HuRI),
reporting an interaction with MISP.
action: MARK_AS_OVER_ANNOTATED
reason: Uninformative generic term from a high-throughput map with no established
functional relationship to CRBN.
supported_by:
- reference_id: PMID:32296183
supporting_text: >-
A reference map of the human binary protein interactome.
reference_section_type: ABSTRACT
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32814053
qualifier: enables
review:
summary: Bare protein binding from a neurodegenerative-disease interactome screen,
reporting interactions with PMP22, KLF11 and COL26A1.
action: MARK_AS_OVER_ANNOTATED
reason: Uninformative generic term from a high-throughput screen with no established
functional link to CRBN's E3-ligase function.
supported_by:
- reference_id: PMID:32814053
supporting_text: Interactome mapping providing a network of neurodegenerative-disease
proteins, reporting CRBN interactions including with PMP22, KLF11 and COL26A1.
full_text_unavailable: true
reference_section_type: ABSTRACT
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:35271311
qualifier: enables
review:
summary: Protein-binding annotation from the OpenCell endogenous-tagging study,
reporting interaction with DDB1.
action: MARK_AS_OVER_ANNOTATED
reason: The DDB1 interaction is biologically central (it defines CRBN's incorporation
into CRL4), but the generic protein binding term is uninformative; complex membership
is already captured by the Cul4-RING complex annotations.
supported_by:
- reference_id: PMID:35271311
supporting_text: >-
OpenCell: Endogenous tagging for the cartography of human cellular organization.
reference_section_type: ABSTRACT
- term:
id: GO:0031333
label: negative regulation of protein-containing complex assembly
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: Transferred by orthology from rat Crbn (Q56AP7), reflecting CRBN's regulation
of BK channel assembly/surface expression via KCNT1.
action: KEEP_AS_NON_CORE
reason: The underlying biology (CRBN regulating ion-channel complex assembly)
is supported in rodent models, but this is a peripheral neuronal role transferred
by orthology, not the core E3-ligase function.
supported_by:
- reference_id: file:human/CRBN/CRBN-uniprot.txt
supporting_text: Likely to function by regulating the assembly and neuronal
surface expression of BK channels via its interaction with KCNT1.
reference_section_type: OTHER
- term:
id: GO:0031334
label: positive regulation of protein-containing complex assembly
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: Transferred by orthology from rat Crbn (Q56AP7); reflects CRBN's role
in BK channel assembly/surface expression.
action: KEEP_AS_NON_CORE
reason: As with the negative-regulation counterpart, this is an ortholog-transferred
peripheral neuronal role rather than the core E3 function; retained as non-core.
supported_by:
- reference_id: file:human/CRBN/CRBN-uniprot.txt
supporting_text: Likely to function by regulating the assembly and neuronal
surface expression of BK channels via its interaction with KCNT1.
reference_section_type: OTHER
- term:
id: GO:0034766
label: negative regulation of monoatomic ion transmembrane transport
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: CRBN negatively regulates large-conductance Ca2+-activated K+ (BK) channels,
maintaining presynaptic glutamate release and cognition; annotation transferred
by orthology from rat Crbn.
action: KEEP_AS_NON_CORE
reason: Supported by rodent functional studies (PMID:29530986; UniProt FUNCTION)
and explains MRT2-related cognitive phenotypes, but is a distinct neuronal role
separate from the core E3-ligase function.
supported_by:
- reference_id: file:human/CRBN/CRBN-uniprot.txt
supporting_text: Maintains presynaptic glutamate release and consequently cognitive
functions, such as memory and learning, by negatively regulating large-conductance
calcium-activated potassium (BK) channels in excitatory neurons.
reference_section_type: OTHER
- term:
id: GO:0035641
label: locomotory exploration behavior
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: Behavioral term transferred by orthology from mouse Crbn (Q8C7D2).
action: KEEP_AS_NON_CORE
reason: Reflects organism-level behavioral phenotypes of rodent Crbn (consistent
with CRBN's neuronal/BK-channel role) but is far removed from the molecular
function and rests only on ortholog transfer.
supported_by:
- reference_id: file:human/CRBN/CRBN-uniprot.txt
supporting_text: May also be involved in regulating anxiety-like behaviors via
a BK channel-independent mechanism (By similarity).
reference_section_type: OTHER
- term:
id: GO:0044325
label: transmembrane transporter binding
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: enables
review:
summary: Reflects CRBN's interaction with the KCNT1 channel and the BK channel,
transferred by orthology from rat Crbn.
action: KEEP_AS_NON_CORE
reason: A more informative MF than bare protein binding (channel binding underlies
CRBN's neuronal role) and supported by interaction data, but peripheral to the
core substrate-receptor function and based on ortholog transfer.
supported_by:
- reference_id: file:human/CRBN/CRBN-uniprot.txt
supporting_text: Likely to function by regulating the assembly and neuronal
surface expression of BK channels via its interaction with KCNT1.
reference_section_type: OTHER
- term:
id: GO:0048471
label: perinuclear region of cytoplasm
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: located_in
review:
summary: Perinuclear cytoplasmic localization transferred by orthology from rat
Crbn.
action: KEEP_AS_NON_CORE
reason: A plausible sub-cytoplasmic localization consistent with the experimentally
supported cytoplasm annotation, but based only on ortholog transfer and not
core function.
supported_by:
- reference_id: file:human/CRBN/CRBN-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Membrane; Peripheral
membrane protein.'
reference_section_type: OTHER
- term:
id: GO:0016567
label: protein ubiquitination
evidence_type: IEA
original_reference_id: GO_REF:0000041
qualifier: involved_in
review:
summary: As the substrate receptor of CRL4(CRBN), CRBN mediates ubiquitination
of target proteins; this UniPathway-mapped term is a core process.
action: ACCEPT
reason: Directly supported by experimental evidence (PMID:20223979 IMP) and central
to CRBN function.
supported_by:
- reference_id: PMID:20223979
supporting_text: >-
CRBN forms an E3 ubiquitin ligase complex with damaged DNA binding protein 1 (DDB1) and
Cul4A that is important for limb outgrowth and expression of the fibroblast growth
factor Fgf8 in zebrafish and chicks.
reference_section_type: ABSTRACT
- term:
id: GO:0031464
label: Cul4A-RING E3 ubiquitin ligase complex
evidence_type: NAS
original_reference_id: PMID:25108355
qualifier: part_of
review:
summary: CRBN is a component of the CUL4A variant CRL4-CRBN E3 ubiquitin ligase
complex (ComplexPortal CPX-2759).
action: ACCEPT
reason: Core complex membership; structurally and biochemically established (PMID:25108355
Cul4-Rbx1-DDB1-Cereblon complex). Redundant with the IDA annotation to the
same term.
supported_by:
- reference_id: PMID:25108355
supporting_text: The Cul4-Rbx1-DDB1-Cereblon E3 ubiquitin ligase complex is
the target of thalidomide, lenalidomide and pomalidomide.
reference_section_type: ABSTRACT
- term:
id: GO:0031465
label: Cul4B-RING E3 ubiquitin ligase complex
evidence_type: NAS
original_reference_id: PMID:25108355
qualifier: part_of
review:
summary: CRBN is also a component of the CUL4B variant CRL4-CRBN E3 ubiquitin
ligase complex (ComplexPortal CPX-2762).
action: ACCEPT
reason: CRBN can assemble with either CUL4A or CUL4B; the CUL4B-variant complex
is documented in ComplexPortal and is a valid core complex membership.
supported_by:
- reference_id: file:human/CRBN/CRBN-uniprot.txt
supporting_text: ComplexPortal; CPX-2762; CRL4-CRBN E3 ubiquitin ligase complex,
CUL4B variant.
reference_section_type: OTHER
- term:
id: GO:0030177
label: positive regulation of Wnt signaling pathway
evidence_type: IMP
original_reference_id: PMID:34489457
qualifier: involved_in
review:
summary: CRBN mediates Wnt-induced, IMiD-independent degradation of CK1alpha (a
negative regulator of Wnt) and is required for physiological Wnt signaling.
action: KEEP_AS_NON_CORE
reason: Experimentally supported (PMID:34489457) and conserved, but a downstream
physiological consequence of the E3-ligase activity rather than CRBN's core
molecular function.
supported_by:
- reference_id: PMID:34489457
supporting_text: >-
Herein we demonstrate that Wnt, the extracellular ligand of an essential signal
transduction pathway, promotes the CRBN-dependent degradation of a subset of proteins.
reference_section_type: ABSTRACT
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9681169
qualifier: located_in
review:
summary: Cytosolic localization from Reactome (CRBN binds IMiDs), consistent with
the experimentally supported cytoplasm annotation.
action: ACCEPT
reason: Consistent with direct cytoplasmic localization data; a localization rather
than core function.
supported_by:
- reference_id: PMID:20223979
supporting_text: Subcellular localization analysis showed CRBN in the nucleus
and cytoplasm.
full_text_unavailable: true
reference_section_type: ABSTRACT
- term:
id: GO:0043161
label: proteasome-mediated ubiquitin-dependent protein catabolic process
evidence_type: IMP
original_reference_id: PMID:20223979
qualifier: involved_in
review:
summary: CRBN, as the substrate receptor of CRL4(CRBN), directs substrates for
ubiquitin-dependent proteasomal degradation; a core process.
action: ACCEPT
reason: Directly supported by experimental evidence; central to CRBN function.
supported_by:
- reference_id: PMID:20223979
supporting_text: >-
CRBN forms an E3 ubiquitin ligase complex with damaged DNA binding protein 1 (DDB1) and
Cul4A that is important for limb outgrowth and expression of the fibroblast growth
factor Fgf8 in zebrafish and chicks.
reference_section_type: ABSTRACT
- term:
id: GO:0031464
label: Cul4A-RING E3 ubiquitin ligase complex
evidence_type: IDA
original_reference_id: PMID:20223979
qualifier: part_of
review:
summary: CRBN was directly shown to form a DCX/CRL4 complex with DDB1, RBX1 and
CUL4A.
action: ACCEPT
reason: Core complex membership supported by direct experimental identification
of the DCX complex.
supported_by:
- reference_id: PMID:20223979
supporting_text: CRBN forms an E3 ubiquitin ligase complex with damaged DNA
binding protein 1 (DDB1) and Cul4A.
reference_section_type: ABSTRACT
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:20223979
qualifier: enables
review:
summary: Protein-binding annotation capturing the direct CRBN-DDB1 interaction
that incorporates CRBN into the CRL4 complex.
action: MARK_AS_OVER_ANNOTATED
reason: The DDB1 interaction is biologically central but the generic protein binding
term is uninformative; complex membership is already captured by the Cul4-RING
complex annotations, and the adaptor MF is better represented by the proposed
substrate-adaptor term.
supported_by:
- reference_id: PMID:20223979
supporting_text: CRBN forms an E3 ubiquitin ligase complex with damaged DNA
binding protein 1 (DDB1) and Cul4A.
reference_section_type: ABSTRACT
- term:
id: GO:0005634
label: nucleus
evidence_type: IDA
original_reference_id: PMID:20223979
qualifier: located_in
review:
summary: Direct immunolocalization places CRBN in the nucleus.
action: ACCEPT
reason: Experimentally supported localization (IDA); a location rather than the
core function.
supported_by:
- reference_id: PMID:20223979
supporting_text: Subcellular localization analysis showed CRBN in the nucleus
and cytoplasm.
full_text_unavailable: true
reference_section_type: ABSTRACT
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IDA
original_reference_id: PMID:20223979
qualifier: located_in
review:
summary: Direct immunolocalization places CRBN in the cytoplasm; CRBN acts in
both the nucleus and cytoplasm, consistent with substrate degradation in both
compartments.
action: ACCEPT
reason: Experimentally supported localization (IDA); a location rather than the
core function. The dual nucleus/cytoplasm distribution is further corroborated
by the falcon deep research synthesis.
supported_by:
- reference_id: PMID:20223979
supporting_text: Subcellular localization analysis showed CRBN in the nucleus
and cytoplasm.
full_text_unavailable: true
reference_section_type: ABSTRACT
- reference_id: file:human/CRBN/CRBN-deep-research-falcon.md
supporting_text: Cereblon is localized in both the nucleus and cytoplasm, enabling
it to ubiquitinate and degrade substrates in multiple cellular compartments
reference_section_type: OTHER
- term:
id: GO:0016567
label: protein ubiquitination
evidence_type: IMP
original_reference_id: PMID:20223979
qualifier: involved_in
review:
summary: CRBN mediates ubiquitination of target proteins as the substrate receptor
of CRL4(CRBN); a core process.
action: ACCEPT
reason: Directly supported by experimental evidence (IMP) and central to CRBN
function.
supported_by:
- reference_id: PMID:20223979
supporting_text: >-
CRBN forms an E3 ubiquitin ligase complex with damaged DNA binding protein 1 (DDB1) and
Cul4A that is important for limb outgrowth and expression of the fibroblast growth
factor Fgf8 in zebrafish and chicks.
reference_section_type: ABSTRACT
- term:
id: GO:1990756
label: ubiquitin-like ligase-substrate adaptor activity
evidence_type: IDA
original_reference_id: PMID:26909574
qualifier: enables
review:
summary: CRBN is the substrate receptor/adaptor of the CRL4(CRBN) E3 ubiquitin
ligase, recruiting substrates (and drug-induced neosubstrates) for ubiquitination.
It has no intrinsic catalytic activity but confers substrate specificity to
the complex.
action: NEW
reason: The existing GOA set lacks any molecular function term for CRBN's actual
role. GO:1990756 ubiquitin-like ligase-substrate adaptor activity is the precise,
well-supported MF and is proposed as a new annotation. The substrate-adaptor
(non-catalytic) nature is corroborated by the falcon deep research synthesis.
proposed_replacement_terms:
- id: GO:1990756
label: ubiquitin-like ligase-substrate adaptor activity
supported_by:
- reference_id: PMID:26909574
supporting_text: IMiDs bind CRBN, the substrate receptor of the CUL4-RBX1-DDB1-CRBN
(also known as CRL4(CRBN)) E3 ubiquitin ligase.
reference_section_type: ABSTRACT
- reference_id: file:human/CRBN/CRBN-deep-research-falcon.md
supporting_text: CRBN does not possess enzymatic activity itself but rather acts
as an adapter protein that confers substrate specificity to the ubiquitination
machinery
reference_section_type: OTHER
core_functions:
- description: CRBN is the substrate-recognition subunit of the CRL4(CRBN) cullin-RING
E3 ubiquitin ligase, binding DDB1 through its N-terminal Lon-like domain and recruiting
substrate proteins through its C-terminal CULT (thalidomide-binding) domain to
direct their ubiquitination and proteasomal degradation.
molecular_function:
id: GO:1990756
label: ubiquitin-like ligase-substrate adaptor activity
directly_involved_in:
- id: GO:0016567
label: protein ubiquitination
- id: GO:0043161
label: proteasome-mediated ubiquitin-dependent protein catabolic process
locations:
- id: GO:0005737
label: cytoplasm
- id: GO:0005634
label: nucleus
in_complex:
id: GO:0031464
label: Cul4A-RING E3 ubiquitin ligase complex
supported_by:
- reference_id: PMID:20223979
supporting_text: CRBN forms an E3 ubiquitin ligase complex with damaged DNA binding
protein 1 (DDB1) and Cul4A.
reference_section_type: ABSTRACT
- reference_id: PMID:26909574
supporting_text: IMiDs bind CRBN, the substrate receptor of the CUL4-RBX1-DDB1-CRBN
(also known as CRL4(CRBN)) E3 ubiquitin ligase.
reference_section_type: ABSTRACT
- description: CRBN binds thalidomide-class drugs (thalidomide, lenalidomide, pomalidomide)
and molecular-glue/PROTAC degraders in its CULT domain; drug binding acts as a
molecular glue that reprograms CRBN substrate specificity to recruit neosubstrates
(e.g. IKZF1, IKZF3, CK1alpha) for degradation. This neosubstrate recruitment is
drug-induced rather than an endogenous function.
molecular_function:
id: GO:1990756
label: ubiquitin-like ligase-substrate adaptor activity
supported_by:
- reference_id: PMID:25108355
supporting_text: These drugs directly bind Cereblon (CRBN) and promote the recruitment
of substrates Ikaros (IKZF1) and Aiolos (IKZF3) to the E3 complex, thus leading
to substrate ubiquitination and degradation.
reference_section_type: ABSTRACT
- reference_id: PMID:26909574
supporting_text: IMiDs also repurpose the ligase to target new proteins for degradation.
reference_section_type: ABSTRACT
proposed_new_terms: []
suggested_questions:
- question: Beyond MEIS2, GLUL and ILF2, what is the full endogenous (IMiD-independent)
substrate repertoire of human CRL4(CRBN), and which degrons does CRBN recognize
natively?
experts:
- Handa H
- Ebert BL
- question: Is CRBN's regulation of BK/KCNT1 channels mediated by ubiquitination of
a channel-associated substrate, or by a non-degradative scaffolding mechanism?
experts:
- Choi SY
- Park CS
suggested_experiments:
- hypothesis: CRBN has a defined set of endogenous neosubstrate-independent substrates
whose stabilization explains the developmental phenotypes seen on CRBN loss.
description: Perform global diGly (K-epsilon-GG) ubiquitinome and quantitative proteomics
comparing CRBN-knockout and wild-type human cells in the absence of any IMiD,
to define drug-independent CRL4(CRBN) substrates.
experiment_type: ubiquitinome and degradation proteomics
- hypothesis: CRBN regulates BK channel surface expression through the CRL4 ubiquitin
ligase activity rather than a degradation-independent scaffold function.
description: Compare BK/KCNT1 channel surface expression and current in neurons
expressing wild-type CRBN, a DDB1-binding-deficient mutant, and a ligase-dead
CRL4 context, using surface biotinylation and electrophysiology.
experiment_type: electrophysiology and surface-expression assay
references:
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000041
title: Gene Ontology annotation based on UniPathway vocabulary mapping
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping, accompanied by conservative changes to GO terms applied by
UniProt
findings: []
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to
orthologs using Ensembl Compara
findings: []
- id: PMID:20223979
title: Identification of a primary target of thalidomide teratogenicity.
findings:
- statement: CRBN forms a CRL4 E3 ubiquitin ligase with DDB1 and Cul4A required
for limb outgrowth and FGF8 expression; thalidomide binds CRBN and inhibits
this ligase activity.
supporting_text: CRBN forms an E3 ubiquitin ligase complex with damaged DNA binding
protein 1 (DDB1) and Cul4A that is important for limb outgrowth and expression
of the fibroblast growth factor Fgf8 in zebrafish and chicks.
reference_section_type: ABSTRACT
- id: PMID:25108355
title: Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for
responsiveness to thalidomide analogs.
findings:
- statement: The Cul4-Rbx1-DDB1-Cereblon E3 ubiquitin ligase is the target of IMiDs,
which bind CRBN and promote recruitment of IKZF1/IKZF3 for ubiquitination and
degradation.
supporting_text: These drugs directly bind Cereblon (CRBN) and promote the recruitment
of substrates Ikaros (IKZF1) and Aiolos (IKZF3) to the E3 complex, thus leading
to substrate ubiquitination and degradation.
reference_section_type: ABSTRACT
- id: PMID:25416956
title: A proteome-scale map of the human interactome network.
findings: []
- id: PMID:26131937
title: Lenalidomide induces ubiquitination and degradation of CK1ฮฑ in del(5q) MDS.
findings:
- statement: Lenalidomide induces CRL4(CRBN)-dependent, proteasome- and cullin-dependent
ubiquitination and degradation of CK1alpha.
supporting_text: Lenalidomide induces the ubiquitination of casein kinase 1A1
(CK1alpha) by the E3 ubiquitin ligase CUL4-RBX1-DDB1-CRBN (known as CRL4(CRBN)),
resulting in CK1alpha degradation.
reference_section_type: ABSTRACT
- id: PMID:26909574
title: Structural basis of lenalidomide-induced CK1ฮฑ degradation by the CRL4(CRBN)
ubiquitin ligase.
findings:
- statement: CRBN is the substrate receptor of CRL4(CRBN); CK1alpha binding is strictly
IMiD-dependent, illustrating drug-induced neosubstrate recruitment.
supporting_text: We show that CK1alpha binding to CRL4(CRBN) is strictly dependent
on the presence of an IMiD.
reference_section_type: ABSTRACT
- id: PMID:31515488
title: Extensive disruption of protein interactions by genetic variants across the
allele frequency spectrum in human populations.
findings: []
- id: PMID:32296183
title: A reference map of the human binary protein interactome.
findings: []
- id: PMID:32814053
title: Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins
and Uncovers Widespread Protein Aggregation in Affected Brains.
findings: []
- id: PMID:34489457
title: The E3 ubiquitin ligase component, Cereblon, is an evolutionarily conserved
regulator of Wnt signaling.
findings:
- statement: CRBN mediates Wnt-induced, IMiD-independent degradation of CK1alpha
and is required for physiological Wnt signaling.
supporting_text: Wnt promotes the CRBN-dependent degradation of a subset of proteins.
These substrates include Casein kinase 1alpha (CK1alpha), a negative regulator
of Wnt signaling.
reference_section_type: ABSTRACT
- id: PMID:35271311
title: 'OpenCell: Endogenous tagging for the cartography of human cellular organization.'
findings: []
- id: Reactome:R-HSA-9681169
title: CRBN binds IMiDs
findings: []
- id: file:human/CRBN/CRBN-deep-research-falcon.md
title: Falcon deep research report for CRBN
reference_review:
relevance: HIGH
correctness: UNVERIFIED
review_notes: 'LLM-synthesized deep-research report (Edison/falcon). Cited using
author-year keys rather than resolvable PMIDs, so individual citations could
not be confirmed against cached publications; marked UNVERIFIED. Content is
consistent with the established picture: it correctly frames CRBN as a non-catalytic
substrate-receptor/adaptor of CRL4(CRBN) and explicitly distinguishes endogenous
substrates (MEIS2, SLO1/KCNMA1, ILF2) from drug-induced neosubstrates (IKZF1/3,
CK1alpha, GSPT1, SALL4) recruited only in the presence of IMiDs/CELMoDs. It
adds mechanistic detail on G-loop degron recognition and open/closed conformational
dynamics that is drug-/neosubstrate-centric and should not be over-interpreted
as endogenous function. Used here to corroborate the substrate-adaptor molecular
function and dual nucleus/cytoplasm localization, not to alter any experimental
annotation.'
findings:
- statement: CRBN is a non-catalytic substrate-recognition adaptor of the CRL4(CRBN)
E3 ubiquitin ligase that confers substrate specificity to the ubiquitination
machinery.
supporting_text: CRBN does not possess enzymatic activity itself but rather acts
as an adapter protein that confers substrate specificity to the ubiquitination
machinery
reference_section_type: OTHER